Low-grade (stage IA and IB) primary lung cancers showed low levels of nuclear E-cadherin, nuclear β-catenin and CD133, and high levels of membranous E-cadherin and membranous β-catenin. This evidence concerns the gene PROM1 and lung carcinoma.